XML 19 R5.htm IDEA: XBRL DOCUMENT v3.25.2
Consolidated Statements of Changes in Equity - USD ($)
$ in Thousands
Total
Total Shareholders' Equity
Common Stock
Common Stock
Stock Appreciation Rights (SARs)
Accumulated Earnings (Deficit)
Accumulated Other Comprehensive Loss
Non-Controlling Interests
Beginning balance ( in shares) at Dec. 31, 2023     162,659,155        
Beginning balance at Dec. 31, 2023 $ 379,205 $ 375,246 $ 733,450   $ (356,258) $ (1,946) $ 3,959
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 3,638 3,639     3,639   (1)
Shares issued for cash by at-the-market offering (in shares)     619,910        
Shares issued for cash by at-the-market offering 4,898 4,898 $ 4,898        
Share issuance cost (110) (110) (110)        
Shares issued for the vesting of restricted stock units 1,345 1,345 $ 1,345        
Shares issued for exercise of stock appreciation rights (in shares)     29,116 89,794      
Cash paid to settle and fund employee income tax withholding due upon exercise of stock appreciation rights (552) (552) $ (552)        
Shares issued for exercise of stock options 103 103 $ 103        
Shares issued for the vesting of restricted stock units (in shares)     253,922        
Cash paid to fund employee income tax withholding due upon vesting of restricted stock units (837) (837) $ (837)        
Ending balance (in shares) at Mar. 31, 2024     163,651,897        
Ending balance at Mar. 31, 2024 387,690 383,732 $ 738,297   (352,619) (1,946) 3,958
Beginning balance ( in shares) at Dec. 31, 2023     162,659,155        
Beginning balance at Dec. 31, 2023 379,205 375,246 $ 733,450   (356,258) (1,946) 3,959
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) (2,781)            
Other comprehensive loss 0            
Ending balance (in shares) at Jun. 30, 2024     163,661,111        
Ending balance at Jun. 30, 2024 382,736 378,779 $ 739,762   (359,037) (1,946) 3,957
Beginning balance ( in shares) at Mar. 31, 2024     163,651,897        
Beginning balance at Mar. 31, 2024 387,690 383,732 $ 738,297   (352,619) (1,946) 3,958
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) (6,419) (6,418)     (6,418)   (1)
Other comprehensive loss 0            
Shares issued for the vesting of restricted stock units   1,412 $ 1,412        
Shares issued for exercise of stock appreciation rights (in shares)     9,214        
Shares issued for exercise of stock options   53 $ 53        
Ending balance (in shares) at Jun. 30, 2024     163,661,111        
Ending balance at Jun. 30, 2024 382,736 378,779 $ 739,762   (359,037) (1,946) 3,957
Beginning balance ( in shares) at Dec. 31, 2024     198,666,994        
Beginning balance at Dec. 31, 2024 531,677 527,794 $ 937,889   (404,023) (6,072) 3,883
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) (26,324) (26,297)     (26,297)   (27)
Other comprehensive loss (597) (597)       (597)  
Shares issued for cash by at-the-market offering (in shares)     15,807,475        
Shares issued for cash by at-the-market offering 79,695 79,695 $ 79,695        
Share issuance cost (2,072) (2,072) (2,072)        
Shares issued for the vesting of restricted stock units 2,832 2,832 $ 2,832        
Shares issued for exercise of stock appreciation rights (in shares)     70,070        
Cash received from non-controlling interest 759           759
Shares issued for exercise of stock options 123 123 $ 123        
Shares issued for the vesting of restricted stock units (in shares)     293,306        
Cash paid to fund employee income tax withholding due upon vesting of restricted stock units (664) (664) $ (664)        
Ending balance (in shares) at Mar. 31, 2025     214,837,845        
Ending balance at Mar. 31, 2025 585,429 580,814 $ 1,017,803   (430,320) (6,669) 4,615
Beginning balance ( in shares) at Dec. 31, 2024     198,666,994        
Beginning balance at Dec. 31, 2024 531,677 527,794 $ 937,889   (404,023) (6,072) 3,883
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) (48,164)            
Other comprehensive loss 3,091            
Ending balance (in shares) at Jun. 30, 2025     229,424,632        
Ending balance at Jun. 30, 2025 644,769 640,182 $ 1,095,295   (452,132) (2,981) 4,587
Beginning balance ( in shares) at Mar. 31, 2025     214,837,845        
Beginning balance at Mar. 31, 2025 585,429 580,814 $ 1,017,803   (430,320) (6,669) 4,615
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) (21,840) (21,812)     (21,812)   (28)
Other comprehensive loss 3,688 3,688       3,688  
Shares issued for cash by at-the-market offering (in shares)     14,584,450        
Shares issued for cash by at-the-market offering 76,313 76,313 $ 76,313        
Share issuance cost   (2,057) (2,057)        
Shares issued for the vesting of restricted stock units   3,202 3,202        
Shares issued for exercise of stock options   34 $ 34        
Shares issued for the vesting of restricted stock units (in shares)     2,337        
Ending balance (in shares) at Jun. 30, 2025     229,424,632        
Ending balance at Jun. 30, 2025 $ 644,769 $ 640,182 $ 1,095,295   $ (452,132) $ (2,981) $ 4,587